Retrospective Study on the Use of CEFALY® Device During Migraine Attacks
1 other identifier
observational
807
0 countries
N/A
Brief Summary
This is an Internet survey to collect data on the use of the Cefaly device to treat migraine attacks in regular Cefaly users.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 19, 2015
CompletedFirst Posted
Study publicly available on registry
November 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMay 8, 2017
May 1, 2017
1 month
November 19, 2015
May 5, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Monthly number of acute drug intake avoided when using Cefaly to treat a migraine attack
On average, mean number of anti-migraine acute drug intake avoided per month per patient in regular Cefaly users, based on self reported average monthly number of attacks and percentage of attacks treated successfully with the Cefaly
Maximum 1 year
Secondary Outcomes (3)
Proportion of Cefaly users that report using also the device to treat migraine attacks
Maximum 1 year
Proportion of migraine attacks treated with the Cefaly device
Maximum 1 year
Proportion of migraine attacks for which the use of the Cefaly device generate a reduction of drug intake
Maximum 1 year
Eligibility Criteria
French speaking patients in Belgium, Switzerland and France, having ordered new electrodes during the last year will be identified as regular users.
You may qualify if:
- Subjects using Cefaly device regularly for more than a year identify by reordering of electrodes during the last year.
- History of likely episodic or chronic migraine with or without aura diagnosed by a physician
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Penning S, Schoenen J. A survey on migraine attack treatment with the CEFALY(R) device in regular users. Acta Neurol Belg. 2017 Jun;117(2):547-549. doi: 10.1007/s13760-017-0757-z. Epub 2017 Feb 9. No abstract available.
PMID: 28185179RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2015
First Posted
November 30, 2015
Study Start
November 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
May 8, 2017
Record last verified: 2017-05